Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: Differences among three standards for the MacCAT-CR in patients with schizophrenia
Introduction
In recent years, there have been frequent suggestions that, in at least some contexts or for certain clinical populations, investigators should systematically evaluate whether potential research participants are competent to consent (National Bioethics Advisory Commission, 1998, UCSD Human Research Protections Program, 2004). The MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR) (Appelbaum and Grisso, 2001) is generally recognized as the best of currently available scales for this purpose (Dunn et al., 2006c, Sturman, 2005); it is also the most widely used in empirical research on consent capacity (Jeste et al., 2006, Vellinga et al., 2004).
Adequate performance on the MacCAT-CR was used in one large-scale clinical trial as part of the criteria for independent consent (Stroup et al., 2003). In most studies, however, capacity assessment has been limited to asking participants a few questions about their understanding of the study. Even in the aforementioned trial, the inclusion criteria focused solely on the MacCAT-CR Understanding subscale, without considering the other three generally recognized dimensions of decisional capacity (Appelbaum and Roth, 1982) also measured on the MacCAT-CR (appreciation of the significance of the information, reasoning with the information, and expressing a choice).
Because of the contextual nature of decisional capacity (Saks et al., 2006), the MacCAT-CR has no established cut-score or algorithm for categorical determinations of capacity or incapacity. This is appropriate, as studies vary in level of risk and in the risk/benefit ratio. General consensus exists that as the degree of risk increases, a higher level of capacity is desirable (Roberts and Dyer, 2004). Thus, no particular level of ability is determinative of adequate capacity in all circumstances (Appelbaum and Grisso, 2001). Moreover, scores on capacity assessment instruments, though helpful, should generally be supplemented with other important information, such as mental status and decision-making context (Appelbaum and Grisso, 2001).
Moreover, discussion of cutpoints is inseparable from considerations of capacity assessment serving a screening function, and from growing evidence regarding educational interventions for enhancing consent. Substantively inadequate responses to MacCAT-CR items indicate a need for further consideration of an individual's decisional abilities, and perhaps for intervention prior to enrollment—rather than as justification for making a definitive categorical decision about decisional capacity. Given that healthy controls often score less than perfectly on the MacCAT-CR (Jeste et al., 2006), perfect MacCAT-CR performance would be an untenable criterion. Rather, each investigator (and/or institutional review board, or IRB) must make some a priori decisions about what level and type of performance constitute “adequate” or “inadequate” performance, raising several key questions: how much understanding is “enough”? Are certain items particularly critical? Even when understanding is adequate, what weight should be given to a less-than-perfect performance on appreciation and/or reasoning?
These issues go beyond application and interpretation of the MacCAT-CR, reflecting genuine lack of consensus regarding what defines adequate consent capacity and under what conditions. Absent such consensus, or empirical or regulatory guidance, investigators and IRBs may make idiosyncratic decisions that may not represent a contextually appropriate balance among the goals of protecting potentially vulnerable persons, fostering important research, and respecting individuals' decision-making autonomy.
The goal of the present study was to evaluate the effects of altering some of these factors (requisite level of understanding, and additional consideration of appreciation and reasoning) on the determination of “adequate" performance on one measure related to decisional abilities (the MacCAT-CR). Although no single cut-score or algorithm on the MacCAT-CR is likely to be appropriate across all protocols or populations, there have been several MacCAT-CR cut-scores published in the literature for specific contexts (Carpenter et al., 2000, Kim et al., 2001, Stroup et al., 2005). We applied these three criteria to our sample to document the extent of disparity in the proportion of subjects categorized as having inadequate performance, and the specific sources of discrepancies under the three criteria. Our goal was not to validate any of these for general use, but rather to make explicit the sources of disagreement to foster discussion and stimulate further empirical research regarding the dimensions and degree of decisional capacity appropriately viewed as essential under differing circumstances.
Section snippets
Participants
Included 91 individuals, aged ≥ 50 years, with schizophrenia (n = 58) or schizoaffective disorder (n = 33), enrolled in a larger study on informed consent and capacity to consent to research among older persons with psychoses. Inclusion criteria were: DSM-IV diagnosis of schizophrenia or schizoaffective disorder (determined by the patient's clinician), current age ≥ 50 years, fluency in English, and the absence of a diagnosis of dementia. Recruitment sources included board-and-care residences, county
Results
Demographic characteristics, MacCAT-CR subscale scores, psychopathology ratings, and cognitive test scores are shown in Table 1. The mean psychopathology rating scales and cognitive scores suggest on average participants had mild symptoms, and mild-to-moderate cognitive impairment.
Using the standards of MacCAT-CR Understanding > 15 and Understanding ≥ 20, 92.3% and 81.3% of participants had adequate performance, respectively, but under the multidimensional standard incorporating Appreciation and
Discussion
Different standards for MacCAT-CR performance resulted in substantially different proportions of individuals with schizophrenia or schizoaffective disorder being categorized as having adequate or inadequate MacCAT-CR performance. Fully half of this sample of middle-aged and older people with schizophrenia and schizoaffective disorder fell into a gray zone of performance—“adequate” by the least stringent standard but “inadequate” by the more stringent and multidimensional standards. Adding
Acknowledgments
This work was supported by NIMH grants MH66062, MH66248, MH64722, by the National Alliance for Research on Schizophrenia and Depression, and by the VA San Diego Healthcare System. These data have been presented in part at the 2005 Annual Meeting of the American College of Neuropsychopharmacology, and at the 2006 Annual Meeting of the American Association for Geriatric Psychiatry.
References (49)
- et al.
Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders
Am. J. Geriatr. Psychiatry
(2002) - et al.
Coercion and informed consent in research involving prisoners
Compr. Psychiatry
(2004) - et al.
Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial
Schizophr. Res.
(2005) The capacity to consent to treatment and research: a review of standardized assessment tools
Clin. Psychol. Rev.
(2005)Decisional capacity of patients with schizophrenia to consent to research: taking stock
Schizophr. Bull.
(2006)- et al.
MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research
(2001) - et al.
Competency to consent to research: a psychiatric overview
Arch. Gen. Psychiatry
(1982) Brief Visual-Spatial Memory Test-Revised. Professional Manual
(1997)- et al.
Hopkins Verbal Learning Test-revised: normative data and analysis of inter-form and test–retest reliability
Clin. Neuropsychol.
(1998) - et al.
A self-report insight scale for psychosis: reliability, validity and sensitivity to change
Acta Psychiatr. Scand.
(1994)
Decisional capacity for informed consent in schizophrenia research
Arch. Gen. Psychiatry
Cognitive changes and the ageing brain
Clinical versus actuarial judgment
Science
Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument
Am. J. Psychiatry
Emerging empirical evidence on the ethics of schizophrenia research
Schizophr. Bull.
Assessing capacity to consent to treatment and research: a review of instruments
Am. J. Psychiatry
Interventions to improve research participants' understanding in informed consent for research: a systematic review
JAMA
A rating scale for depression
J. Neurol. Neurosurg. Psychiatry
The stability and course of neuropsychological deficits in schizophrenia
Arch. Gen. Psychiatry
Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: an overview
Schizophr. Bull.
The positive and negative syndrome scale (PANSS) for schizophrenia
Schizophr. Bull.
When does decisional impairment become decisional incompetence? Ethical and methodological issues in capacity research in schizophrenia
Schizophr. Bull.
Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research
Am. J. Psychiatry
Wisconsin Card Sorting Test-64 Card Version. Professional Manual
Cited by (46)
Reconsidering research exclusion for serious mental illness: Ethical principles, current status, and recommendations
2021, Journal of Psychiatric ResearchPsychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia
2016, Psychiatry ResearchCitation Excerpt :Our study also identified a negative correlation between MMSE score and the understanding and appreciation scores involved in the regression model. This finding is compatible with those of prior studies that reveal that cognition is related to DMC (Stroup et al., 2005; Dunn et al., 2007; Palmer and Savla, 2007; Candilis et al., 2008). Likewise, one study used an assessment similar to the MacCAT-CR, the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) (Grisso et al., 1997), to measure assent to receive treatment among patients with schizophrenia.
Research with dementia patients?
2015, Ethics, Medicine and Public HealthCitation Excerpt :But in any case the refusal of even an incompetent patient must be respected. Empirical findings show that further research is needed in order to differentiate procedures of assessment of the capacity to consent and in order to qualify ethically the application of the findings [18,25]. This is necessary because the Alzheimer dementia impairs differently various mental functions, which may influence the capacity to consent, e.g. the self-awareness of cognitive mnestic deficits much more (up to anosognosia) than the self-awareness of one's own identity or one's own body [26].
Validation of Chinese version of the MacArthur competence assessment tool for clinical research (MacCAT-CR) in patients with schizophrenia spectrum disorders
2013, Psychiatry ResearchCitation Excerpt :Possible explanations for the discrepancies between this study and ours, respectively, could be the source of patients (mostly outpatients vs. all inpatients), severity of psychopathology (mean PANSS scores: 58 vs. 63), and rating instrument of insight (Birchwood Insight Scale Total vs. PANSS-G12). Our study found a positive correlation between the MMSE and MacCAT-CR scores, which matches the findings of prior studies that found cognitive function is associated with DMC (Dunn et al., 2007; Stroup et al., 2005). Our finding is compatible with a study showed that cognitive function is the primary predictor of DMC with regard to consent to clinical research (Palmer and Jeste, 2006).
“You Aren't Going to Cut On Me!” Urgent Medical Decisions for Patients With Schizophrenia
2018, PsychosomaticsCitation Excerpt :Once the decision had been made, Mr. B verbally assented to the procedure on the way to the operating room and had an uneventful surgery and recovery. Decisional capacity assessments for patients with both schizophrenia and refusal of urgent, irreversible treatments present dilemmas for the C-L psychiatrist.6–9 An adequate assessment requires weighing the usual decisional capacity criteria: communication of consistent preference, understanding the relevant information, appreciation of the situation and consequences (both of treatment and nontreatment), and appropriate application of information to one’s personal situation.2,9,13
Decision making capacity for treatment in psychiatric inpatients: A systematic review and meta-analysis
2024, Psychological Medicine